|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|
| Cash Flows from Operating Activities: | |||
| Net income | |||
| Adjustments to reconcile net income to net cash used in operating activities: | |||
| Interest earned on cash and investment held in Trust Account | |||
| Changes in operating assets and liabilities: | |||
| Prepaid expenses | |||
| Accrued expense | |||
| Payable—related party | |||
| Payable - related party | |||
| Net cash used in operating activities | |||
| Cash Flows from Investing Activities: | |||
| Purchase of investment held in trust account | |||
| Investment of Cash in Trust Account | |||
| Withdraw of investment held in trust account | |||
| Net cash used in investing activities | |||
| Cash Flows from Financing Activities: | |||
| Proceeds from sale of public units through public offering | |||
| Payment of underwriters' discount | |||
| Payment of underwriters’ discount | |||
| Payment of offering costs | |||
| Ordinary shares redemption | |||
| Proceeds from issuance of promissory from founder | |||
| Proceeds from extension loan | |||
| Proceeds from working capital loan | |||
| Net cash provided in financing activities | |||
| Net Change in Cash | |||
| Cash at beginning of year | |||
| Cash at end of year | |||
| Deferred offering costs paid by promissory note-related party | |||
| Reclassification of ordinary shares subject to redemption | |||
| Accretion of carrying value to redemption value | |||
| Supplemental Disclosure of Non-cash Financing Activities | |||
| Reclassification of ordinary shares subject to redemption | |||
| Deferred underwriters’ discount | |||
| Settlement of deferred offering costs | |||
| Payable – related party paid expenses on behalf of the Company | |||
| Extension funds attributable to ordinary shares subject to redemption | |||
| Accretion of carrying value to redemption value |
Loading...
